Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer

Author's Avatar
Oct 27, 2022

Better+Therapeutics%2C+Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, announced today that Diane Gomez-Thinnes joined the company as Chief Commercial Officer starting October 26, 2022.